Compounding Pharmacy · Franklin, TN · 503A

DCA Pharmacy Review

DCA Pharmacy is one of the largest 503A compounding pharmacies in Tennessee, located in Franklin, TN, and licensed to ship to 48 states. Specializes in bio-identical hormone replacement, topical pain management, scar therapy, pellet therapy, and sterile compounding. Named in a 2023 Novo Nordisk lawsuit over compounded semaglutide; the case was voluntarily dismissed.

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

503AState pharmacy license
Location: Franklin, TN
States licensed: 49
6.0
★★★☆☆3/5

Editorial score · methodology

Top-Rated GLP-1 Partners

Not sourced from DCA Pharmacy — these are our highest-scored vetted telehealth partners for compounded GLP-1s, if you'd rather start with a provider we've walked through end to end.

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

No insurance needed · HSA/FSA eligible · vetted by our editors

7.2

Fella Health

Men's weight loss

Starting price: $299/mo

Get started →Read review Fella Health →
7.6

SkinnyRx

Mainstream telehealth GLP-1 access

Starting price: $149.25/mo

Get started →Read review SkinnyRx →
7.8

Embody

Low flat-rate compounded GLP-1 pricing at every dose

Starting price: $79/mo

Get started →Read review Embody →
6.9

YourEra

$99 first-month entry pricing on compounded GLP-1s

Starting price: $149/mo

Get started →Read review YourEra →

Certifications & Compliance

All sterile compounding pharmacies in the United States are required to follow United States Pharmacopeia General Chapter <797> sterile compounding standards[4], with finished preparations evaluated against USP <71> sterility testing[5] and USP <85> bacterial endotoxin testing[6] as appropriate for the product type.

State pharmacy license
Licensed by the pharmacy's home state board of pharmacy. All US pharmacies must hold a state license at minimum.
503A
Traditional patient-specific compounding pharmacy under Section 503A — compounds individual prescriptions and is regulated primarily by its state board of pharmacy.

Drugs Produced

Compounding pharmacies' ability to produce semaglutide or tirzepatide depends on the FDA Drug Shortage List status for each reference product; compounding eligibility can change when a drug moves on or off the shortage list[7].

Semaglutide
Compounded semaglutide produced
Tirzepatide
Compounded tirzepatide produced

States Licensed (49)

ALAKAZARCACOCTDEFLGAHIIDILINIAKSKYLAMEMDMAMIMNMSMOMTNENVNHNJNMNYNCNDOHOKORPARISDTNTXUTVTVAWAWVWIWY

Regulatory Actions

2023-XX-XX
Named in Novo Nordisk Inc. v. DCA Pharmacy, Case No. 3:23-cv-00668 (M.D. Tenn. 2023), alleging trademark infringement on compounded semaglutide marketing. Novo voluntarily dismissed the case; DCA remains operationally active.

Weight Loss Rankings Score Breakdown

Accreditation & Compliance6/10
Regulatory Standing5/10
State Coverage10/10
GLP-1 Production10/10
Track Record5/10

Scores are independently researched. See our methodology for details.

Medium confidence · Last verified 2026-05-23 via pharmacy-directory-cross-state-audit-2026-05-23 · How we verify provider data

Frequently Asked Questions

DCA Pharmacy is a 503A compounding pharmacy based in Franklin, TN. It operates under state board of pharmacy licensure. Note: our records show 1 documented regulatory action(s) — see the Regulatory Actions section below.
DCA Pharmacy is headquartered in Franklin, TN. The pharmacy is licensed to ship to 49 US states.
DCA Pharmacy produces compounded semaglutide and compounded tirzepatide in addition to other compounded preparations. As a 503A pharmacy, it dispenses compounded medications in response to individual patient prescriptions under state board of pharmacy oversight.
503A pharmacies prepare compounded medications for individual patients in response to specific prescriptions and are regulated primarily by state boards of pharmacy under USP <797> sterile compounding standards. 503B outsourcing facilities register directly with the FDA, follow current Good Manufacturing Practices (cGMP), and can produce compounded medications in larger batches without patient-specific prescriptions. 503B facilities are subject to FDA inspection.

Key terms, explained

New to GLP-1s? Tap any term for a quick, plain-English definition.

See Top Semaglutide ProvidersAll Pharmacies
Sources & methodology — as of October 2026
  1. 1.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
  2. 2.FDA — 503B Outsourcing Facility Registration and Requirements— U.S. Food & Drug Administration.
  3. 3.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
  4. 4.USP General Chapter <797> — Pharmaceutical Compounding: Sterile Preparations— United States Pharmacopeia.
  5. 5.USP General Chapter <71> — Sterility Tests— United States Pharmacopeia.
  6. 6.USP General Chapter <85> — Bacterial Endotoxins Test— United States Pharmacopeia.
  7. 7.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.